Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysis
Authors
Keywords
Electrochemotherapy, Ipilimumab, Pembrolizumab, Nivolumab, Melanoma, Immune checkpoint blockade
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 8, Pages 951-959
Publisher
Springer Nature
Online
2016-06-14
DOI
10.1007/s00262-016-1856-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer
- (2015) Gregor Sersa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Abscopal-Effekt in der Therapie des malignen Melanoms
- (2015) C. Thallinger et al. HAUTARZT
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
- (2015) Antoni Ribas et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy
- (2015) Nicola Mozzillo et al. OncoImmunology
- Efficacy and Safety of Nivolumab in Patients With BRAF V600 Mutant and BRAF Wild-Type Advanced Melanoma
- (2015) James Larkin et al. JAMA Oncology
- Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy
- (2014) Paola Queirolo et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
- (2014) Paola Queirolo et al. JOURNAL OF NEURO-ONCOLOGY
- Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
- (2014) Antonio M Grimaldi et al. OncoImmunology
- Utility of electrochemotherapy in melanoma treatment
- (2012) Alessandro Testori et al. CURRENT OPINION IN ONCOLOGY
- Antitumor effectiveness of electrochemotherapy: A systematic review and meta-analysis
- (2012) B. Mali et al. EJSO
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Final Version of 2009 AJCC Melanoma Staging and Classification
- (2009) Charles M. Balch et al. JOURNAL OF CLINICAL ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation